Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Warning Letters

Warning Letters

                        About Warning and Close-Out Letters Home
          Inspections, Compliance, Enforcement, and Criminal Investigations
          Compliance Actions and Activities
          Warning Letters
          Martin Farm, Konrad Martin - 664784 - 11/14/2023Warning Letters WARNING LETTER
      Martin Farm, Konrad Martin
            
      MARCS-CMS 664784 —           November 14, 2023


    
Share
    Post
    Linkedin

    Email
    PrintDelivery Method: 
        VIA EMAIL AND UNITED PARCEL SERVICE
      
      
              Product: 
        Animal & VeterinaryFood & Beverages            


Recipient:

                      Recipient Name
              Mr. Konrad Martin
                                Recipient Title
              Part Owner
          
            Martin Farm, Konrad Martin

          
                      68572 Country Road 11Nappanee, IN 46550-8946United States
          
          
            
            (b)(6), (b)(7)(C)            

       Issuing Office:
        
         
          Division of Human and Animal Food Operations East VI
        
         
          United StatesSecondary Issuing Offices
          United States

 

 

**WARNING LETTER
CMS 664784**

November 14, 2023
Mailing Address:**(b)(6), (b)(7)(C)**

Dear Mr. Martin:

An inspection of your dairy operation located at 68572 Country Road 46, Nappanee, Indiana, was conducted by representatives of the U.S. Food and Drug Administration (FDA) on May 24, 2023, and June 21, 2023. This letter notifies you of violations of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) that were revealed during our inspection of your operation. You can find the FD&C Act and its associated regulations on the Internet through links on the FDA’s webpage at www.fda.gov.

At the close of the inspection, you were issued a form FDA 483, Inspectional Observations (FDA 483). We have not received a response to the FDA 483 as of the date of this letter.

**Adulteration of an Animal Offered for Human Consumption**

Our inspection found that you hold animals under conditions that are so inadequate that medicated animals bearing potentially harmful drug residues are likely to enter the food supply. Specifically, you failed to maintain complete and accurate treatment records. For example, you do not maintain any treatment records for drugs administered to calves on your farm, nor do you keep complete treatment records of drugs administered to cattle on your farm as those records lack dose, total days of treatment, route of administration, and person medicating animal and calves.

Food held under such conditions is adulterated.***1***

**Adulteration of a New Animal Drug**

We also found that you did not use **(b)(4)** (enrofloxacin, **(b)(4)**) and **(b)(4)** (ceftiofur hydrochloride, **(b)(4)**) as directed by their approved labeling and prescription labels. Use of a drugs in a manner that is not consistent with its labeling is an extralabel use.***2***

Our inspection found that you administered **(b)(4)** to calves without following the animal class, indications for use, route of administration, and withdrawal time. During the inspection, you stated that you administer **(b)(4)** of **(b)(4)** to prevent and treat scours and respiratory disease in most calves, either intramuscularly (IM) or orally with milk, and you do not follow meat withdrawal periods. This drug is not approved for use in calves or for disease prevention purposes for scours, and cannot be administered IM or orally or used without a meat withhold period. Extra-label use of **(b)(4)** is prohibited.***3***

Our inspection also found that you used **(b)(4)** without following the labeled dose. For example, during the inspection you explained that you used **(b)(4)** by giving **(b)(4)**. This drug is labeled for administering no more than **(b)(4)** per injection site. **(b)(4)**, a ceftiofur class drug, is prohibited from extra label use.***4***

Because your use of these drugs was not in conformance with their approved labeling and did not comply with 21 CFR Part 530, you caused the drugs to be unsafe and adulterated.***5*** The introduction or delivery for introduction into interstate commerce of any drug that is adulterated is a prohibited act.***6***

**Conclusion**

This letter is not intended to be an all-inclusive statement of violations that may exist at your facility. You are responsible for investigating and determining the cause of any violations and for preventing their recurrence or the occurrence of other violations. It is your responsibility to ensure that your firm complies with all requirements of federal law and FDA regulations.

This letter notifies you of our concerns and provides you an opportunity to address them. Failure to adequately address this matter may lead to legal or regulatory action without further notice, including without limitation, seizure and/or injunction.

Within fifteen (15) working days of receipt of this letter, please notify this office in writing of the specific steps that you have taken to correct any violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation. If you cannot complete corrective actions within fifteen (15) working days, state the reason for the delay and the time within which you will complete the correction. If you believe that you have complied with the FD&C Act and FDA regulations, include your reasoning and any supporting information for our consideration.

Your written response should be sent to Dylan C. Grippi, Compliance Officer, at 300 River Place Drive, Suite 5900, Detroit, MI 48207 or via email (preferred) to Dylan.Grippi@fda.hhs.gov. If you have any questions about this letter, please contact Mr. Grippi at (301)-452-1608, or by e-mail at Dylan.Grippi@fda.hhs.gov.

Sincerely,
/S/

William R. Weissinger, MS
Program Division Director
Office of Human and Animal Food Operations East Division 6

CC: **(b)(4)**

___________________

***1*** See section 402(a)(4) of the FD&C Act [21 U.S.C. § 342(a)(4)]

***2*** See 21 CFR 530.3(a).

***3*** See 21 CFR 530.41(a)(10).

***4*** See 21 CFR 530.41(a)(13)(ii).

***5*** Under section 501(a)(5) of the FD&C Act [21 U.S.C. § 351(a)(5)], a new animal drug is deemed adulterated if it is unsafe within the meaning of section 512 of the FD&C Act [21 U.S.C. § 360b].

***6*** See section 301(a) of the FD&C Act [21 U.S.C. § 331(a)]

                                                                                  Content current as of:
      01/30/2024
               
                
Regulated Product(s)
		 Animal & Veterinary
			  			     			  			     Food & BeveragesMore Warning Letters

     
    Warning Letters

          
                        About Warning and Close-Out Letters
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop